Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Key Highlights: GLP-1s Reshape the Market: Sales of GLP-1 drugsoriginally for type-2 diabetes but now widely prescribed for weight managementdrove much of the first-quarter growth
Collaborative Care: We work closely with endocrinologists and primary care physicians to ensure comprehensive management of both diabetes and foot health
)
2021 (Nature Communications) This study asked whether MOTS-c could restore physical performance in aged mice
Roughly 1 in 8 (12%) consumers have taken a GLP-1 drug , per KFF, and that share is likely to rise: 26% of US consumers plan to take a weight loss drug to achieve their 2025 New Year's resolution goals , per Tebra
US$ 29.71
US$ 24.88
US$ 21.14
US$ 22.30
US$ 29.11
